Back
Adaptive Biotechnologies Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
30
ADPT
Adaptive Biotechnologies
Last Price:
$7.34
Seasonality Move:
11.6%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADPT is experiencing slight selling pressure.
Adaptive Biotechnologies Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.81 | Sell |
20-day SMA: | 7.88 | Sell |
50-day SMA: | 7.89 | Sell |
200-day SMA: | 5.88 | Buy |
8-day EMA: | 7.74 | Sell |
20-day EMA: | 7.79 | Sell |
50-day EMA: | 7.67 | Sell |
200-day EMA: | 6.34 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 45.92 | Sell |
Chaikin Money Flow: | -100005 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.39 - 8.17) | Sell |
Bollinger Bands (100): | (6.17 - 8.17) | Buy |
Adaptive Biotechnologies Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 7.49 while ADPT 8-day simple moving average is 7.81, which is a Sell signal.
-
The stock price of ADPT is 7.49 while Adaptive Biotechnologies 20-day SMA is 7.88, which makes it a Sell.
-
Adaptive Biotechnologies 50-day simple moving average is 7.89 while ADPT share price is 7.49, making it a Sell technically.
-
ADPT stock price is 7.49 and Adaptive Biotechnologies 200-day simple moving average is 5.88, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Sell
30
Adaptive Biotechnologies (ADPT)
is a Sell
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a SellThe current Adaptive Biotechnologies [ADPT] share price is $7.49. The Score for ADPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
1.1B
Price in USD:
7.49
Share Volume:
860K
Adaptive Biotechnologies 52-Week Range
52-Week High:
9.01
52-Week Low:
2.28
Sell
30
Adaptive Biotechnologies (ADPT)
is a Sell
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?The Adaptive Biotechnologies stock price is 7.49 USD today.
-
Will ADPT stock go up or go down?Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptive Biotechnologies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is overvalued.
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 7.49 while ADPT 8-day exponential moving average is 7.74, which is a Sell signal.
-
The stock price of ADPT is 7.49 while Adaptive Biotechnologies 20-day EMA is 7.79, which makes it a Sell.
-
Adaptive Biotechnologies 50-day exponential moving average is 7.67 while ADPT share price is 7.49, making it a Sell technically.
-
ADPT stock price is 7.49 and Adaptive Biotechnologies 200-day simple moving average is 6.34, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.19 per share, and an increase next year of $0.27 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
-
ADPT Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Adaptive Biotechnologies is a Sell
-
Adaptive Biotechnologies Relative Strength Index (RSI) is 45.92, which suggest Adaptive Biotechnologies is oversold
-
The Bollinger Bands (25) for Adaptive Biotechnologies is (7.39 - 8.17), which suggest Adaptive Biotechnologies is a Buy
-
The Bollinger Bands (100) for Adaptive Biotechnologies is (6.17 - 8.17), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.